Abstract
Efforts to combat the risk of overdose and substance use disorder (SUD) associated with prescription stimulant misuse could receive a boost from new meta‐analytic findings that higher‐than‐recommended doses of the medications show little benefit in the treatment of attention deficit hyperactivity disorder (ADHD).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
